Your browser doesn't support javascript.
loading
Addiction Research Consortium: Losing and regaining control over drug intake (ReCoDe)-From trajectories to mechanisms and interventions.
Heinz, Andreas; Kiefer, Falk; Smolka, Michael N; Endrass, Tanja; Beste, Christian; Beck, Anne; Liu, Shuyan; Genauck, Alexander; Romund, Lydia; Banaschewski, Tobias; Bermpohl, Felix; Deserno, Lorenz; Dolan, Raymond J; Durstewitz, Daniel; Ebner-Priemer, Ulrich; Flor, Herta; Hansson, Anita C; Heim, Christine; Hermann, Derik; Kiebel, Stefan; Kirsch, Peter; Kirschbaum, Clemens; Koppe, Georgia; Marxen, Michael; Meyer-Lindenberg, Andreas; Nagel, Wolfgang E; Noori, Hamid R; Pilhatsch, Maximilian; Priller, Josef; Rietschel, Marcella; Romanczuk-Seiferth, Nina; Schlagenhauf, Florian; Sommer, Wolfgang H; Stallkamp, Jan; Ströhle, Andreas; Stock, Ann-Kathrin; Winterer, Georg; Winter, Christine; Walter, Henrik; Witt, Stephanie; Vollstädt-Klein, Sabine; Rapp, Michael A; Tost, Heike; Spanagel, Rainer.
Afiliação
  • Heinz A; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin (Campus Charité Mitte), Berlin, Germany.
  • Kiefer F; Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Smolka MN; Department of Psychiatry and Neuroimaging Centre, Technische Universität Dresden, Dresden, Germany.
  • Endrass T; Institute for Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany.
  • Beste C; Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Technische Universität Dresden, Dresden, Germany.
  • Beck A; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin (Campus Charité Mitte), Berlin, Germany.
  • Liu S; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin (Campus Charité Mitte), Berlin, Germany.
  • Genauck A; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin (Campus Charité Mitte), Berlin, Germany.
  • Romund L; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin (Campus Charité Mitte), Berlin, Germany.
  • Banaschewski T; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Bermpohl F; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin (Campus Charité Mitte), Berlin, Germany.
  • Deserno L; Department of Psychiatry and Neuroimaging Centre, Technische Universität Dresden, Dresden, Germany.
  • Dolan RJ; Max Planck Centre for Computational Psychiatry and Ageing Research & Wellcome Centre for Human Neuroimaging, University College London, London, UK.
  • Durstewitz D; Max Planck Centre for Computational Psychiatry and Ageing Research & Wellcome Centre for Human Neuroimaging, University College London, London, UK.
  • Ebner-Priemer U; Department of Theoretical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Flor H; Department of Sports and Sports Science, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
  • Hansson AC; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Heim C; Department of Psychology, School of Social Sciences, University of Mannheim, Mannheim, Germany.
  • Hermann D; Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Kiebel S; Institute of Medical Psychology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Kirsch P; Department of Biobehavioral Health, Pennsylvania State University, University Park, Pennsylvania.
  • Kirschbaum C; Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Koppe G; Feuerlein Center on Translational Addiction Medicine (FCTS), University of Heidelberg, Heidelberg, Germany.
  • Marxen M; Department of Psychiatry and Neuroimaging Centre, Technische Universität Dresden, Dresden, Germany.
  • Meyer-Lindenberg A; Department of Psychology and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.
  • Nagel WE; Department of Clinical Psychology, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Noori HR; Department of Psychology, Biological Psychology, Technische Universität Dresden, Dresden, Germany.
  • Pilhatsch M; Department of Theoretical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Priller J; Department of Psychiatry and Neuroimaging Centre, Technische Universität Dresden, Dresden, Germany.
  • Rietschel M; Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Romanczuk-Seiferth N; Center for Information Services and High Performance Computing, Technische Universität Dresden, Dresden, Germany.
  • Schlagenhauf F; Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Sommer WH; Max Planck Institute for Biological Cybernetics, Tübingen, Germany.
  • Stallkamp J; Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
  • Ströhle A; Department of Neuropsychiatry and Laboratory of Molecular Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Stock AK; UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK.
  • Winterer G; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Winter C; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin (Campus Charité Mitte), Berlin, Germany.
  • Walter H; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin (Campus Charité Mitte), Berlin, Germany.
  • Witt S; Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Vollstädt-Klein S; Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Rapp MA; Project Group for Automation in Medicine and Biotechnology, Fraunhofer IPA, Mannheim, Germany.
  • Tost H; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin (Campus Charité Mitte), Berlin, Germany.
  • Spanagel R; Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Technische Universität Dresden, Dresden, Germany.
Addict Biol ; 25(2): e12866, 2020 03.
Article em En | MEDLINE | ID: mdl-31859437
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Comportamental / Telemedicina / Transtornos Relacionados ao Uso de Substâncias / Sinais (Psicologia) / Pesquisa Biomédica Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Comportamental / Telemedicina / Transtornos Relacionados ao Uso de Substâncias / Sinais (Psicologia) / Pesquisa Biomédica Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article